Insider Transactions in Q1 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
511
-2.52%
|
$19,929
$39.2 P/Share
|
|
Feb 22
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,738
+7.89%
|
-
|
|
Feb 22
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,002
-0.8%
|
$78,078
$39.2 P/Share
|
|
Feb 22
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,056
+1.59%
|
-
|
|
Feb 22
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,058
-0.76%
|
$41,262
$39.2 P/Share
|
|
Feb 22
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,318
+1.64%
|
-
|
|
Feb 22
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-0.96%
|
$13,767
$39.2 P/Share
|
|
Feb 22
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,159
+3.05%
|
-
|
|
Feb 22
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
652
-0.27%
|
$25,428
$39.2 P/Share
|
|
Feb 22
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,883
+0.76%
|
-
|
|
Feb 22
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-2.11%
|
$13,182
$39.2 P/Share
|
|
Feb 22
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,159
+6.76%
|
-
|
|
Feb 22
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
488
-0.97%
|
$19,032
$39.2 P/Share
|
|
Feb 22
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,594
+3.08%
|
-
|
|
Feb 22
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,099
-1.02%
|
$42,861
$39.2 P/Share
|
|
Feb 22
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,028
+1.84%
|
-
|
|
Feb 22
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,157
-8.47%
|
$45,123
$39.2 P/Share
|
|
Feb 22
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,607
+16.03%
|
-
|
|
Feb 21
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-0.58%
|
$61,712
$38.03 P/Share
|
|
Feb 21
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,661
+1.29%
|
-
|
|
Feb 21
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-1.8%
|
$25,118
$38.03 P/Share
|
|
Feb 21
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+4.47%
|
-
|
|
Feb 21
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-0.24%
|
$17,404
$38.03 P/Share
|
|
Feb 21
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,558
+0.81%
|
-
|
|
Feb 21
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,209
-1.34%
|
$45,942
$38.03 P/Share
|
|
Feb 21
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,726
+2.94%
|
-
|
|
Feb 21
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,462
-0.36%
|
$283,556
$38.03 P/Share
|
|
Feb 21
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,824
+0.79%
|
-
|
|
Feb 21
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
275
-1.46%
|
$10,450
$38.03 P/Share
|
|
Feb 21
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
934
+4.72%
|
-
|
|
Feb 21
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,922
-0.77%
|
$73,036
$38.03 P/Share
|
|
Feb 21
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,894
+1.54%
|
-
|
|
Feb 21
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.93%
|
$11,324
$38.03 P/Share
|
|
Feb 21
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,012
+3.05%
|
-
|
|
Feb 21
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-0.7%
|
$36,822
$38.03 P/Share
|
|
Feb 21
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,804
+1.99%
|
-
|
|
Feb 21
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
219
-0.61%
|
$8,322
$38.03 P/Share
|
|
Feb 21
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
623
+1.71%
|
-
|
|
Feb 21
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
593
-0.24%
|
$22,534
$38.03 P/Share
|
|
Feb 21
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+0.7%
|
-
|
|
Feb 21
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
529
-3.96%
|
$20,102
$38.03 P/Share
|
|
Feb 21
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+7.55%
|
-
|
|
Feb 21
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
223
-1.48%
|
$8,474
$38.03 P/Share
|
|
Feb 21
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
779
+4.92%
|
-
|
|
Feb 21
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-1.28%
|
$14,782
$38.03 P/Share
|
|
Feb 21
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,324
+4.19%
|
-
|
|
Feb 21
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.68%
|
$12,692
$38.03 P/Share
|
|
Feb 21
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+2.18%
|
-
|
|
Feb 21
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-0.87%
|
$35,264
$38.03 P/Share
|
|
Feb 21
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,713
+1.58%
|
-
|